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Pregnancy is both desired and demanding for every woman of 
reproductive age. It is essentially a period that a woman’s body 
undergoes adaptive physiological changes to accommodate 
fetal growth. One of the potential complications during this 
period is the emergence of pregnancy-induced hypertension 
and preeclampsia, commonly associated with increased 
maternal and infant mortality and morbidity.[1] Preeclampsia 
is a progressive, multi-systemic disorder characterized by 
triad of high blood pressure (BP) (≥140/90 mmHg), edema, 
and proteinuria (>300 mg/day), developing after 20 weeks of 
gestation.[1] Incidence of preeclampsia has been estimated at 
5–14% pregnancies worldwide, 4–18% in developing countries 
with increasing trend.[2,3] It has been found that preeclampsia has 
more impact in developing countries where pregnant women 
have been reported to consume diets with lesser amounts of 
essential minerals and vitamins.[1] During pregnancy, inadequate 
nutrition might be harmful not only to the mother but also to 
the growing fetus.[1] The pathophysiology of preeclampsia 
likely involves maternal-fetal physiological perturbations. 
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Abstract
Background: Evidence suggests the involvement of calcium and magnesium metabolism 
in the pathophysiology of preeclampsia. However, findings from studies are heterogenous 
and inconsistent. Aim: The study aimed to compare the total serum calcium and 
magnesium levels in preeclamptic women with that of normotensive pregnant women. 
Subjects and Methods: A cross‑sectional subjects of eighty pregnant women living in Abakaliki, 
Ebonyi state, South‑East Nigeria, were recruited into the study. The present study compared 
serum calcium and magnesium in forty preeclamptic (cases) and forty normotensive (control) 
pregnant women matched for age, parity, and socioeconomic status. Serum calcium and 
magnesium levels were measured using atomic absorption spectrophotometer. Statistical 
analysis was done using SPSS Version 20 statistical software. Differences between means 
were compared using Student’s t‑test with P < 0.05 considered as statistically significant. 
Results: While the mean serum calcium was comparable between preeclamptic and 
normotensive pregnant women (13.99 [3.29] vs. 14.02 [5.68] µg/dl), the preeclamptic 
pregnant women have significantly (P < 0.001) lower serum magnesium in comparison to their 
normotensive counterparts (3.22 [1.05] vs. 4.15 [0.78]). Conclusion: It may be concluded 
that serum magnesium seems to play a crucial role in the pathophysiology of preeclampsia in 
this environment.
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Although the exact etiology is unknown, the pathophysiological 
mechanism is characterized with the failure of the trophoblastic 
invasion of the spiral arteries, leading to mal-adaptation of 
maternal spiral arterioles, which may be associated with 
an increased vascular resistance of the uterine artery and a 
decreased perfusion of the placenta.[4,5] The implicated vascular 
resistance and under-perfusion of the placenta, according to a 
study,[6] may lead to the release of antiangiogenic factors into 
the maternal circulation and alter maternal systemic endothelial 
function to cause hypertension and other manifestations 
of the disease. Other contributory factors include obesity, 
diabetes, calcium deficiency, maternal age, and job stress.[7,8] 
Consequently, much research has focused on elucidating the 
pathophysiological events that regulate BP in pregnancy.
Recently, nutritional deficiency is gaining prominence in the 
pathogenesis of preeclampsia. Many clinical studies have 
shown the relationship between preeclampsia and perturbations 
in maternal biochemical macronutrients, including calcium and 
magnesium.[1,3,4,9,10] Currently, there is an increased interest in 
the management of preeclampsia with nutritional approach 
in relation to calcium and magnesium supplementation.[11,12] 
However, reports from clinical studies are inconsistent 
on the role of calcium and magnesium in preeclampsia 
development. Some studies have shown that decrease in serum 
calcium and/or magnesium may potentiate pathogenesis of 
preeclampsia,[7,12,13] whereas others have failed to show any 
association of blood levels of the elements and prevalence 
of preeclampsia.[5] Magnesium is a cofactor for enzymes and 
peripheral vasodilator for smooth muscles.[14] Calcium caused 
vasoconstriction by decreasing prostacyclin production and 
by increasing the vasoconstriction effect of angiotensin II 
and noradrenaline in the blood vessel wall.[15,16] Considering 
the physiological importance of calcium and magnesium, it 
appears that alterations in these nutrients during pregnancy 
may be risk and/or predisposing factors to preeclampsia. There 
is a need for further investigations on the role of calcium and 
magnesium in preeclampsia etiology. Thus, the present study 
was designed to investigate the possible role of calcium and 
magnesium in preeclampsia etiopathogenesis among pregnant 
Nigerians in Abakaliki metropolis.
Subjects and Methods
The study was a case–control study carried out between January 
2013 and June 2014 at the Department of Obstetrics and 
Gynecology of the Federal Teaching Hospital, Abakaliki, one 
of the referral tertiary health institutions in the South-Eastern 
part of Nigeria. The study included forty normotensive pregnant 
women (controls) and forty preeclamptic women (PW) (cases) 
who were not on calcium or other supplements attending 
antenatal clinic in the outpatient department of the hospital. 
The sample size determination for case–control studies was 
done according to Cochran’s formula (z = 1.96, confidence 
interval = 95%), with a prevalence of preeclampsia in Nigerian 
population.[17] The selection followed simple random sampling; 
they were matched for age, parity, and socioeconomic status and 
in their second or third trimester of pregnancy. Ethical approval 
for the study was granted by the Ethics and Research Committee 
of the Hospital. The approval was based on the provision of 
Helsinki Declaration (2000) and on the agreement that patient 
anonymity must be maintained, good laboratory practice/quality 
control ensured, and that every finding would be treated with 
utmost confidentiality and for the purpose of this research only. 
Written informed consent to participate in the study was obtained 
from the pregnant women. Sociodemographic and obstetric 
data were obtained with structured questionnaire reliable 
and validated. Following that, the BP was measured using 
mercury sphygmomanometer and stethoscopes (Kris-Alloy®, 
Wuxi Medical Instrument Factory, Wuxi city, Jiangsu, China), 
which was pretested on known nonhypertensives and known 
hypertensives and found to be precise. To ensure the accuracy 
of reading, appropriately sized cuff (cuff bladder encircling 
at least 80% of the arm) was used and the measurement done 
after the subject has been in a sitting resting state for 5 min. The 
subjects were said to be hypertensive according to the WHO/ISH 
criteria when their mean systolic BP (SBP) were ≥140 mmHg, 
and/or when their mean diastolic BP (DBP) was ≥90 mmHg.[18] 
Participants with SBP ≥140 mmHg and/or DBP ≥90 mmHg were 
measured again after at least 30 min interval for confirmatory 
purpose. Height and weight measurements were taken with the 
subjects in light clothing without shoes, caps or head tie on using 
a standard calibrated meter rule affixed to a wall perpendicular 
to a flat, smooth surface floor, whereas the body weight was 
measured using a digital weighing scale (Seca, Hamburg, 
Germany). The body mass index (BMI) was calculated as a 
ratio of the weight in kilogram (kg) and square of height in 
meter (m2).[19] BP was measured with patients in a restful position 
using a sphygmomanometer on at least two occasions.
Preeclamptic women were selected based on the following 
inclusion criteria:
• New onset of hypertension after 20 weeks of gestation 
with BP ≥140/90 mmHg or rise in SBP >30 mmHg and 
DBP >15 mmHg in at least two occasions, above booking 
BP
• Proteinuria >300 mg/day as detected by dipsticks.
Pregnant women with kidney disease, diabetes, endocrine 
disorder, or any other systemic disease/secondary causes of 
hypertension was excluded from the study. Pregnant women 
on calcium supplement, food characterized with high calcium 
or minerals were screened out of the study. Pregnant women 
without hypertension (normotensives) were selected if 
BP < 140/90 mmHg with no increase in SBP up to 30 mmHg 
and DBP up to 15 mmHg due to pregnancy and without 
evidence of proteinuria.
Sample collection
Between 8:00 am and 10:00 am, fasting venous blood (5 ml) 
was collected from antecubital vein without stasis and 
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dispensed into plain plastic bottle (3 ml) while 2 ml was 
dispensed into ethylenediaminetetraacetic acid bottles for 
packed cell volume (PCV) analysis. The serum was separated 
after clotting and stored at −20°C until total calcium and 
magnesium were determined.
Laboratory analysis
Calcium and magnesium were determined using Atomic 
Absorption Spectrophotometer (Buck Scientific, Model AVG 
210),[20] whereas PCV was estimated according to a standard 
method.[21]
Statistical analysis
Statistical analysis was performed using SPSS Version 20 
(Chicago IL, USA). Differences between mean values were 
determined using the Student’s t-test, at P < 0.05 for statistical 
significant difference.
Results
Table 1 depicts the mean age, gestational age, and BMI 
values for normotensive pregnant women and PW. The 
mean age 27.55 (4.23) for normotensive pregnant women 
was not significantly different (P = 0.08) from the mean 
age 29.45 (3.70) for PW. There were statistically significant 
differences (P < 0.001) between the weight, height, and BMI 
for normotensive pregnant women and PW.
In Table 2, mean serum calcium 14.02 (5.68) for normotensive 
pregnant women was statistically comparable (P = 0.98) to 
the PW 13.99 (3.29). However, the magnesium level was 
significantly (P < 0.001) lower in preeclamptic pregnant 
women than in their normotensive counterparts (3.22 [1.05] 
vs. 4.15 [0.78]). The mean PCV for normotensive and 
preeclamptic pregnant women showed no statistically 
significant difference (P = 0.54) (41.07 [5.11] vs. 41.80 [4.24]).
Discussion
Hypertension in pregnancy is an important public health 
challenge, and the research efforts are yet to unravel the 
etiologic cause. Imbalance of physiologically important 
nutrients may progress to deleterious health effects and much 
more in pregnancy state. Studies in Nigeria have reported 
etiologic association of dietary calcium and magnesium with 
preeclampsia, but evidence to support this association is weak, 
inconsistent, and conflicting.[5,7,12,13,22,23]
In the present study, we have analyzed for serum total calcium 
and magnesium for the purpose of comparison between normal 
pregnant women and PW. The BMI of normotensive pregnant 
women was significantly higher than the PW [Table 1]. The 
normotensive pregnant women were overweight, whereas PW 
had normal BMI. However, maternal obesity predisposes a 
woman to developing preeclampsia, and a relationship between 
increasing BMI and the risk of developing preeclampsia is well 
established. Although maternal high BMI is related to adverse 
maternal pregnancy outcomes such as preeclampsia, eclampsia, 
pre- and post-term delivery,[23,24] the reason for the higher BMI 
in the normotensives is obscure. However, genetic factors 
have been associated with the development of hypertension.[25] 
There was no significant difference in the mean serum calcium 
in both pregnant women in this study. This is in contrast with 
several studies[4,15,26] suggesting hypocalcemia as a possible 
cause for preeclampsia. For instance, Guhan et al.[15] and 
Indumati et al.[26] reported significantly lower calcium levels 
in preeclamptic patients and pregnancy-induced hypertension, 
respectively. Moreover, study among pregnant women in 
Bangkok Metropolis reported significantly lower calcium 
levels for severely PW, but no statistical difference was found 
for calcium in mildly preeclamptic group when compared with 
normal pregnancy group.[4] However, in corroboration with our 
current finding, other studies[3,23,27] have refuted the suggestion 
of the involvement of low calcium in the pathogenesis of 
preeclampsia. Earlier studies of Golmohammad et al.[23] and 
Vahidrodsari et al.[27] also concluded that serum calcium 
may not be involved in the pathogenesis of preeclampsia. In 
Nigeria, Adewolu[3] reported no association between serum 
calcium and preeclampsia and concluded that calcium may 
not play a vital role in preeclampsia among the Nigerian 
population. On the basis of the physiological role of dietary 
calcium,[14] epidemiologic studies have shown that restricted 
dietary calcium is associated with increased BP. Such finding 
led to dietary calcium supplementation trials in normotensive 
and hypertensive populations. However, the results from such 
trials have been disappointing. For example, Levine et al.[16] 
in a prospective study in American population showed that 
calcium supplementation during pregnancy did not prevent 
preeclampsia in healthy nulliparous women, although 
Crowther et al.[28] and Herrera et al.[29] reported otherwise.
Magnesium is an essential intracellular cation that contributes 
to neurotransmission and peripheral vasodilation. At the 
Table 1: Comparison of age and body mass index between 
normotensive and preeclamptic womena
Parameters NW (n=40) PW (n=40) P
Age (years) 27.6 (4.23) 29.5 (3.70) 0.08
Gestational age (weeks) 21.5 (3.73) 21.4 (3.22) 0.87
Weight (kg) 71.5 (4.38) 66.4 (5.60) <0.001*
Height (m) 1.66 (0.14) 1.83 (0.16) <0.001*
BMI (kg/m2) 27.2 (5.39) 20.3 (3.90) <0.001*
*P<0.05 (significantly different), aValues are mean (SD). NW: Normotensive women; 
PW: Preeclamptic women, SD: Standard deviation
Table 2: Comparison of calcium, magnesium, packed cell 
volume between normotensive and preeclamptic womena
Parameters NW (n=40) PW (n=40) P
Calcium (mg/dl) 14.0 (5.70) 13.9 (3.30) 0.98
Magnesium (mg/dl) 4.2 (0.78) 3.2 (1.10) <0.001*
PCV (%) 41.1 (5.11) 41.8 (4.24) 0.54
*P<0.05 (significantly different), aValues are mean (SD). NW: Normotensive women, 
PW: Preeclamptic women, PCV: Packed cell volume
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subcellular level, magnesium regulates contractile protein, 
modulates transmembrane transport of calcium, sodium, and 
potassium, act as an essential cofactor in the activation of 
ATPase, controls metabolic regulation of energy-dependent 
cytoplasmic and mitochondrial pathways; regulate 
oxidative‑phosphorylation processes, and influences DNA 
and protein synthesis.[30] The present study showed that serum 
magnesium level in preeclamptic women was significantly 
lower compared to normotensive pregnant women. Various 
studies have suggested the influence of magnesium on fetal 
and maternal morbidity both prepartum and postpartum.[1] 
Previous studies have established inverse association between 
serum magnesium and occurrence of preeclampsia[7,14,15,31,32] 
similar to our report in this study. Both clinical and 
experimental data suggest that alterations in magnesium 
status not only influence vascular contractibility, but also 
vascular smooth muscle cell growth, cardiac excitability, 
an important factor associated with vascular structural 
changes in hypertension.[30] MacDonald et al.[33] have shown 
experimentally that magnesium has a vasoprotective effect. 
However, conflicting data from extensive investigations have 
been reported. Golmohammad et al.[23] in India and Adewolu[3] 
in Nigeria reported no significant difference in magnesium 
levels among normal pregnancy, pregnancy-induced 
hypertension, and preeclampsia. Nonetheless, the evidence 
for causal association between magnesium supplementation 
and BP reduction was weak in a meta-analysis of 12 
randomized trials with follow-up ranging from 8 to 
26 weeks.[34] A dose-response pattern was found in another 
meta-analysis with twenty studies; however, magnesium 
intake only resulted in a small overall reduction in BP, a 
mean of − 0.6 mmHg for SBP and − 0.8 mmHg for DBP.[35] 
On the basis of these data, the authors concluded that the 
relationship between magnesium and hypertension seems 
inconsistent and not convincing.
Conclusion
This study has reported a possible role for magnesium but not 
calcium in the pathogenesis of preeclampsia, with overweight 
BMI in normal pregnant women. Early detection and treatment 
of hypomagnesemia may give beneficial health effect in 
pregnancy-induced hypertension and preeclampsia. However, 
the current conflicting evidence for calcium and magnesium 
role in hypertensive disorders, including preeclampsia, is a 
major challenge confronting universal observation for the use 
of calcium and magnesium supplementation in preeclampsia 
management.
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